The ACTR is a multi-disciplinary collaboration of leading transplant scientists and clinicians sharing a common interest in developing innovative approaches to clinically relevant "bench to bedside" research. The diversity in research background makes the ACTR at Dalhousie University one of the finest in terms of expertise and quality of work. The main focus of this laboratory is the immunopathology of solid organ transplant rejection. Our mission is to improve the quality of life for transplant patients with acute or chronic graft rejection using novel therapies without the side effects of current immunosuppressive drugs.

The key members of the Transplantation Laboratory's research team include:

Dr. Tim Lee, Director, The Atlantic Centre for Transplantation Research
(see research projects section)

Dr. Gregory Hirsch, Head, Division of Cardiac Surgery, QEII Health Sciences Centre

Dr. Bjorn Nashan, Head, Hepatobiliary Surgery, Hamburg, Germany

Dr. J.F. Légaré, Surgical Director, Heart Transplant, Multi-Organ Transplant Program

Dr. Camille Hancock-Friesen, Pediatric Cardiac Surgery, QEII Health Sciences Centre

Dr. Ian Alwayn, General Surgery, Surgical Director - Multi-Organ Transplant Program

Dr. Mark Walsh, General Surgery, Multi-Organ Transplant Program

For more information on clinical transplantation, contact the Multi-Organ Transplant Program for the Atlantic Region, or connect to the MOTP site here.